首页|肌少症与老年局部进展期结直肠癌患者长期预后的相关性分析

肌少症与老年局部进展期结直肠癌患者长期预后的相关性分析

扫码查看
目的 探讨肌少症与老年局部进展期结直肠癌(LACRC)患者长期预后的相关性.方法 回顾性分析2014年1月至2018年12月北京医院接受根治性切除术、TNM分期为Ⅱ~Ⅲ期的205例70岁及以上老年LACRC患者的临床资料,应用术前30 d内的腹部CT测量第3腰椎截面的骨骼肌面积(SMA),肌少症的定义为骨骼肌指数(SMI)(SMI=SMA/身高2)男性≤52.4 cm2/m2、女性≤38.5cm2/m2,比较肌少症和非肌少症两组患者的临床和病理情况,分析肌少症对老年LACRC术后患者长期预后的影响.结果 205例患者中,63.4%(130/205)患者患有肌少症.与非肌少症患者比较,肌少症组患者中80岁及以上高龄老年人比例更高(x2=6.420、P=0.011)、超重或肥胖的比例更低(x2=9.366、P=0.009)、接受辅助化疗比例和术后5年无疾病生存率更低(x2=6.257、7.347,P=0.012、0.007).Kaplan-Meier分析结果显示,非肌少症组的老年LACRC患者无疾病生存(DFS)率优于肌少症组患者(Log-rank x2=6.919、P=0.009);非肌少症组老年LACRC患者中,辅助化疗组DFS率优于非辅助化疗组(Log-rank x2=4.745、P=0.029).多因素Cox回归分析结果显示,TNM 分期为 Ⅲ期(HR=1.634,95%CI:1.110~2.404,P=0.013)和患肌少症(HR=1.509,95%CI:1.017~2.238,P=0.041)是老年LACRC患者长期预后不良的影响因素.结论 肌少症和老龄及体质指数相关,患有肌少症的老年LACRC患者长期预后欠佳,非肌少症的老年LACRC患者可能获益于辅助化疗.
The correlation between sarcopenia and long-term prognosis of elderly patients with local advanced colorectal cancer
Objective To investigate the relationship between sarcopenia and the long-term prognosis of elderly patients with locally advanced colorectal cancer.Methods A retrospective analysis was conducted on clinical data from 205 elderly colorectal cancer patients aged 70 years and above who underwent radical resection with TNM staging of stage Ⅱ to Ⅲ at Beijing Hospital between January 2014 and December 2018.The study utilized abdominal CT scans taken within 30 days before surgery to measure the skeletal muscle area(SMA)of the 3rd lumbar vertebrae cross-section.Sarcopenia was defined as a skeletal muscle index(SMI)of ≤52.4 cm2/m2 in men and≤38.5 cm2/m2 in women(SMI=SMA/height2).A comparison was made between the clinical and pathological conditions of patients with and without sarcopenia in the two groups,with an analysis of the impact of sarcopenia on the long-term prognosis of elderly postoperative colorectal cancer patients.Results Among the 205 patients assessed,63.4%(130/205)were diagnosed with sarcopenia.The group with sarcopenia had a higher percentage of individuals aged 80 years and older(x2=6.420,P=0.011)compared to those without sarcopenia.Additionally,this group had a lower proportion of overweight or obese patients(x2=9.366,P=0.009),fewer patients who underwent adjuvant chemotherapy,and a lower 5-year disease-free survival rate post-surgery(x2=6.257,7.347,P=0.012,0.007).Kaplan-Meier analysis indicated that disease-free survival rate was better in elderly patients with locally advanced colorectal cancer who did not have sarcopenia compared to those with sarcopenia(Log-rank x2=6.919,P=0.009).Moreover,in elderly patients without sarcopenia,those who received adjuvant chemotherapy had a more favorable disease-free survival outcome than those who did not receive such treatment(Log-rank x2=4.745,P=0.029).Multifactorial Cox regression analysis showed that TNM stage Ⅲ(HR=1.634,95%CI:1.110-2.404,P=0.013)and the presence of sarcopenia(HR=1.509,95%CI:1.017-2.238,P=0.041)were significant factors influencing the poor long-term prognosis of elderly patients with locally advanced colorectal cancer.Conclusions Sarcopenia is associated with aging and body mass index,and has been found to be a significant factor in the long-term prognosis of elderly colorectal cancer patients.Those with sarcopenia tend to have a poorer prognosis,while those without may experience benefits from adjuvant chemotherapy.

Colorectal neoplasmsPrognosisSarcopenia

胡雪晴、赵赟博、聂鑫、施红、李琳

展开 >

北京医院肿瘤内科 国家老年医学中心 中国医学科学院老年医学研究院,北京 100730

北京医院老年医学科国家老年医学中心中国医学科学院老年医学研究院,北京 100730

结直肠肿瘤 预后 肌少症

2024

中华老年医学杂志
中华医学会

中华老年医学杂志

CSTPCD北大核心
影响因子:1.606
ISSN:0254-9026
年,卷(期):2024.43(7)
  • 2